Compare MHH & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHH | STIM |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.1M | 88.4M |
| IPO Year | 2008 | 2018 |
| Metric | MHH | STIM |
|---|---|---|
| Price | $7.75 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 27.7K | ★ 1.3M |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $191,371,000.00 | $52,776,000.00 |
| Revenue This Year | N/A | $11.10 |
| Revenue Next Year | $9.07 | $11.92 |
| P/E Ratio | $394.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.51 | $0.80 |
| 52 Week High | $8.37 | $4.84 |
| Indicator | MHH | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 61.90 | 55.17 |
| Support Level | $6.64 | $1.21 |
| Resistance Level | $8.37 | $1.42 |
| Average True Range (ATR) | 0.48 | 0.11 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 86.42 | 61.54 |
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.